Literature DB >> 16110497

Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin.

E Pierri1, K Avgoustakis.   

Abstract

In this work, the feasibility to develop micelle carriers of griseofulvin based on PLA-PEG copolymers was investigated. With the use of the dialysis method of micelle formation, the micellization behavior of a range of PLA(X)-PEG(5) copolymers was investigated. At copolymer concentrations in the organic solvent 10-20 mg/mL, stable micelles with 100% yield could only be prepared from PLA(X)-PEG(5) copolymers with molar composition in the range 50-70% PEG. The copolymers exhibited sufficiently low CMC to provide stable micelles in vivo. The loading capacity of PLA(4)-PEG(5) micelles with griseofulvin was 6.5 mg of drug/1 g of copolymer. The release of griseofulvin from the PLA-PEG micelles in vitro in phosphate-buffered saline (PBS) was sustained over 30 days. No burst effect was observed. Analysis of the release kinetics suggested that the release was erosion-controlled. The release profile was biphasic. Micelle degradation data in PBS indicated that the second phase of release was induced by copolymer degradation. The PLA-PEG micelles of griseofulvin were stable in simulated gastric and intestinal fluids for a long-enough time for oral application. Overall, the PLA-PEG micelles have suitable properties to be considered as potential oral or topical formulations of griseofulvin, provided that the drug-loading capacity of the micelles is sufficiently improved. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110497     DOI: 10.1002/jbm.a.30490

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  22 in total

Review 1.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

2.  Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.

Authors:  Tong Liu; Svetlana Romanova; Shuo Wang; Megan A Hyun; Chi Zhang; Samuel M Cohen; Rakesh K Singh; Tatiana K Bronich
Journal:  Mol Pharm       Date:  2019-06-14       Impact factor: 4.939

3.  Controlled Drug Release from Pharmaceutical Nanocarriers.

Authors:  Jinhyun Hannah Lee; Yoon Yeo
Journal:  Chem Eng Sci       Date:  2015-03-24       Impact factor: 4.311

4.  Comparison of surfactants used to prepare aqueous perfluoropentane emulsions for pharmaceutical applications.

Authors:  Madhuvanthi A Kandadai; Praveena Mohan; Genyao Lin; Anthony Butterfield; Mikhail Skliar; Jules J Magda
Journal:  Langmuir       Date:  2010-04-06       Impact factor: 3.882

Review 5.  Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.

Authors:  Ruchit Trivedi; Uday B Kompella
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

6.  Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel.

Authors:  Sungwon Kim; Ji Young Kim; Kang Moo Huh; Ghanashyam Acharya; Kinam Park
Journal:  J Control Release       Date:  2008-07-10       Impact factor: 9.776

7.  Preparation and evaluation of poly(ethylene glycol)-poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a.

Authors:  Yanhui Zhang; Xinru Li; Yanxia Zhou; Xiaoning Wang; Yating Fan; Yanqing Huang; Yan Liu
Journal:  Nanoscale Res Lett       Date:  2010-03-27       Impact factor: 4.703

8.  Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen.

Authors:  Xinru Li; Zhuoli Yang; Kewei Yang; Yanxia Zhou; Xingwei Chen; Yanhui Zhang; Fei Wang; Yan Liu; Lijun Ren
Journal:  Nanoscale Res Lett       Date:  2009-09-16       Impact factor: 4.703

9.  Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates.

Authors:  Qian Yin; Rong Tong; Yunxiang Xu; Kwanghyun Baek; Lawrence W Dobrucki; Timothy M Fan; Jianjun Cheng
Journal:  Biomacromolecules       Date:  2013-02-27       Impact factor: 6.988

10.  An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.

Authors:  Ofra Benny; Ofer Fainaru; Avner Adini; Flavia Cassiola; Lauren Bazinet; Irit Adini; Elke Pravda; Yaakov Nahmias; Samir Koirala; Gabriel Corfas; Robert J D'Amato; Judah Folkman
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.